Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,936 | -39,848 | -24,491 | -13,176 | -6,567 |
| Depreciation Amortization | 2,058 | 1,577 | 1,066 | 536 | 2,132 |
| Other Working Capital | 31,178 | -3,243 | -3,484 | -2,301 | -46,918 |
| Other Operating Activity | 7,717 | 5,166 | 1,624 | 1,512 | 7,982 |
| Operating Cash Flow | $-13,983 | $-36,348 | $-25,285 | $-13,429 | $-43,371 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -19,058 | 23,370 | 14,400 | 10,972 | 33,675 |
| PPE Investments | -384 | -195 | -135 | -69 | -1,807 |
| Investing Cash Flow | $-19,442 | $23,175 | $14,265 | $10,903 | $31,868 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 3,758 |
| Debt Repayment | -1,565 | -1,206 | -837 | -415 | -1,049 |
| Common Stock Issued | 45,223 | 17,137 | 17,140 | 17,164 | 60 |
| Financing Cash Flow | $43,658 | $15,931 | $16,303 | $16,749 | $2,769 |
| Beginning Cash Position | 19,339 | 19,339 | 19,339 | 19,339 | 28,073 |
| End Cash Position | 29,572 | 22,097 | 24,622 | 33,562 | 19,339 |
| Net Cash Flow | $10,233 | $2,758 | $5,283 | $14,223 | $-8,734 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,983 | -36,348 | -25,285 | -13,429 | -43,371 |
| Capital Expenditure | -384 | -195 | -135 | -69 | -1,807 |
| Free Cash Flow | -14,367 | -36,543 | -25,420 | -13,498 | -45,178 |